Aquestive Therapeutics Inc (AQST):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Aquestive Therapeutics Inc (AQST) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C3035
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:37
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Aquestive Therapeutics Inc (Aquestive Therapeutics) is a pharmaceutical company that discovers, develops and commercializes prescription drug products and a pipeline of prescription formulations. The company offers PharmFilm a drug delivery platform that delivers existing prescription products directly to the bloodstream. Its products include suboxone, rizatriptan, zuplenz, clobazam, diazepam, meloxicam, colchicine, flu vaccine, and others. Aquestive Therapeutics also provides nutraceutical products, packaging solutions, consumer products, and drug products for the treatment of nausea, opioid dependence, and vomiting. The company partners with other pharmaceutical companies for the development and commercialization of pharmaceutical products. It has its operations in New Jersey and Indiana, the US. Aquestive Therapeutics is headquartered in Warren, New Jersey, the US.

Aquestive Therapeutics Inc (AQST) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Aquestive Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Aquestive Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Aquestive Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Aquestive Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Aquestive Therapeutics Inc, Medical Devices Deals, 2012 to YTD 2018 10
Aquestive Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Aquestive Therapeutics Inc, Pharmaceuticals & Healthcare, Deal Details 12
Asset Purchase 12
Monosol Acquires Buccal Film Patent From Fuisz Pharma 12
Venture Financing 13
Aquestive Therapeutics Raises USD9.1 Million in Venture Financing 13
Partnerships 14
Monosol Enters Into Agreement With BiondVax To Develop Oral Delivery For Flu Vaccine 14
Midatech Enters Into Joint Venture With MonoSol Rx 16
Licensing Agreements 17
Aquestive Therapeutics Enters into Licensing Agreement with Mitsubishi Tanabe Pharma 17
Cynapsus Therapeutics Enters into Licensing Agreement with MonoSol Rx 18
Monosol Rx Enters into Licensing Agreement with Galena Biopharma for Zuplenz 19
Monosol Rx Enters Into Licensing Agreement With Vestiq Pharma For Zuplenz 20
Lupin Pharma Enters into Licensing Agreement with MonoSol Rx 21
Equity Offering 22
Aquestive Therapeutics Completes Underwriters Exercise of Over-Allotment Option of IPO of Shares of Shares for USD73.9 Million 22
Aquestive Therapeutics Inc – Key Competitors 24
Aquestive Therapeutics Inc – Key Employees 25
Aquestive Therapeutics Inc – Locations And Subsidiaries 26
Head Office 26
Other Locations & Subsidiaries 26
Joint Venture 26
Recent Developments 27
Corporate Communications 27
May 02, 2018: Aquestive Therapeutics Appoints Nancy Lurker to Board of Directors 27
Apr 11, 2017: MonoSol Rx Appoints James S. Scibetta to Board of Directors 28
Jan 24, 2017: MonoSol Rx Appoints John T. Maxwell as Chief Financial Officer 29
Product News 30
01/18/2018: Aquestive Therapeutics Announces U.S. FDA Filing Acceptance of New Drug Application for Clobazam Oral Soluble Film to Treat Lennox-Gastaut Syndrome 30
01/06/2017: Monosol Rx Successfully Completes Dose Proportionality Study Of Diazepam Buccal Soluble Film To Treat Acute Repetitive Seizures 31
Product Approvals 32
Jan 31, 2018: Aquestive Therapeutics Receives U.S. FDA Orphan Drug Designation for Riluzole Oral Soluble Film to Treat ALS 32
Feb 07, 2017: MonoSol Rx Receives FDA Acceptance of New Drug Application for Tadalafil PharmFilm 33
Jan 04, 2017: MonoSol Rx Receives FDA Acceptance of Investigational New Drug Application for Riluzole Oral Soluble Film to Treat Amyotrophic Lateral Sclerosis 34
Clinical Trials 35
Jan 10, 2017: MonoSol Rx to Initiate Human Proof-of-Concept Study of Epinephrine Sublingual Soluble Film 35
Other Significant Developments 36
Nov 30, 2017: MonoSol Rx Changes Name to Aquestive Therapeutics and Expands CNS Product Portfolio 36
Appendix 37
Methodology 37
About GlobalData 37
Contact Us 37
Disclaimer 37

List of Tables
Aquestive Therapeutics Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Aquestive Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Aquestive Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Aquestive Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Aquestive Therapeutics Inc, Deals By Therapy Area, 2012 to YTD 2018 9
Aquestive Therapeutics Inc, Medical Devices Deals, 2012 to YTD 2018 10
Aquestive Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Monosol Acquires Buccal Film Patent From Fuisz Pharma 12
Aquestive Therapeutics Raises USD9.1 Million in Venture Financing 13
Monosol Enters Into Agreement With BiondVax To Develop Oral Delivery For Flu Vaccine 14
Midatech Enters Into Joint Venture With MonoSol Rx 16
Aquestive Therapeutics Enters into Licensing Agreement with Mitsubishi Tanabe Pharma 17
Cynapsus Therapeutics Enters into Licensing Agreement with MonoSol Rx 18
Monosol Rx Enters into Licensing Agreement with Galena Biopharma for Zuplenz 19
Monosol Rx Enters Into Licensing Agreement With Vestiq Pharma For Zuplenz 20
Lupin Pharma Enters into Licensing Agreement with MonoSol Rx 21
Aquestive Therapeutics Completes Underwriters Exercise of Over-Allotment Option of IPO of Shares of Shares for USD73.9 Million 22
Aquestive Therapeutics Inc, Key Competitors 24
Aquestive Therapeutics Inc, Key Employees 25
Aquestive Therapeutics Inc, Other Locations 26
Aquestive Therapeutics Inc, Joint Venture 26

List of Figures
Aquestive Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Aquestive Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Aquestive Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Aquestive Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Aquestive Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Aquestive Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Aquestive Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Aquestive Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Aquestive Therapeutics Inc, Medical Devices Deals, 2012 to YTD 2018 10

★海外企業調査レポート[Aquestive Therapeutics Inc (AQST):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • South Texas Accelerated Research Therapeutics:製薬・医療:M&Aディール及び事業提携情報
    Summary South Texas Accelerated Research Therapeutics (START) accelerates the development of novel anticancer agents that improves personalized and clinical care for cancer patients. The company offers preclinical and clinical research services which include pharmacokinetics, in vivo and in vitro se …
  • Eldorado Artesian Springs, Inc.:企業の戦略・SWOT・財務情報
    Eldorado Artesian Springs, Inc. - Strategy, SWOT and Corporate Finance Report Summary Eldorado Artesian Springs, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Patterson-UTI Energy, Inc.:企業の戦略・SWOT・財務情報
    Patterson-UTI Energy, Inc. - Strategy, SWOT and Corporate Finance Report Summary Patterson-UTI Energy, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Warburg Pincus LLC:企業の戦略・SWOT・財務分析
    Warburg Pincus LLC - Strategy, SWOT and Corporate Finance Report Summary Warburg Pincus LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Zain Group (ZAIN):企業の財務・戦略的SWOT分析
    Zain Group (ZAIN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Aerostar S.A.:企業の戦略・SWOT・財務分析
    Aerostar S.A. - Strategy, SWOT and Corporate Finance Report Summary Aerostar S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Alon USA Energy, Inc.:企業の戦略・SWOT・財務情報
    Alon USA Energy, Inc. - Strategy, SWOT and Corporate Finance Report Summary Alon USA Energy, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • VAMED AG:企業の戦略・SWOT・財務情報
    VAMED AG - Strategy, SWOT and Corporate Finance Report Summary VAMED AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Indiana Resources Limited:企業の戦略・SWOT・財務分析
    Indiana Resources Limited - Strategy, SWOT and Corporate Finance Report Summary Indiana Resources Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Grupo Elektra, S.A. de C.V.:企業の戦略・SWOT・財務分析
    Grupo Elektra, S.A. de C.V. - Strategy, SWOT and Corporate Finance Report Summary Grupo Elektra, S.A. de C.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Journey Energy Inc (JOY):石油・ガス:M&Aディール及び事業提携情報
    Summary Journey Energy Inc (Journey Energy), a subsidiary of Maples Investments LP, is an oil and gas company that offers exploration, development and production oil and natural gas assets. The company provides horizontal and multi-frac drilling, and secondary recovery methods that helps in acquirin …
  • Alliance Healthcare Services Inc:医療機器:M&Aディール及び事業提携情報
    Summary Alliance Healthcare Services Inc (Alliance Healthcare Services) is a provider of outsourced services including diagnostic imaging services. It provides a full line of services ranging from systems, technologists to operate the systems, sales and marketing, patient scheduling and pre-authoriz …
  • Edison International:企業の戦略・SWOT・財務情報
    Edison International - Strategy, SWOT and Corporate Finance Report Summary Edison International - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Exactech Inc (EXAC):企業の財務・戦略的SWOT分析
    Summary Exactech Inc (Exactech) is a medical device company that offers orthopedic implant devices and related surgical instruments. The company’s products comprise hip implants, shoulder implants, knee implants, extremity implants, biologics and spine, and other products. It also provides biologic …
  • FleetCor Technologies Inc:企業の戦略・SWOT・財務分析
    FleetCor Technologies Inc - Strategy, SWOT and Corporate Finance Report Summary FleetCor Technologies Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Aslan Pharmaceuticals Pte Ltd:企業のM&A・事業提携・投資動向
    Aslan Pharmaceuticals Pte Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Aslan Pharmaceuticals Pte Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and …
  • KOSE Corp:企業の戦略・SWOT・財務情報
    KOSE Corp - Strategy, SWOT and Corporate Finance Report Summary KOSE Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Powerco Ltd:企業の戦略的SWOT分析
    Powerco Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Pakistan Refinery Ltd (PRL):企業の財務・戦略的SWOT分析
    Pakistan Refinery Ltd (PRL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • University of Connecticut:製薬・医療:M&Aディール及び事業提携情報
    Summary University of Connecticut (UCONN) is an educational service provider that offers graduation programs and other courses. The university offers undergraduate degree courses, graduate degree courses, professional degree programs, and research programs. It offers educational and training program …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆